Ticker Sage

Company file · CME

CME Group

MarketData was CME Group's fastest-growing product or service in FY2025, up 13.1%

Revenue rose 6.4% to $6.5B in FY2025, from $6.1B in FY2024. Net income rose 15.5% to $4.1B. clearing and transaction fees was the largest product or service, at 81% of revenue.

Prepared from SEC filings · Latest annual report: 10-K for FY2025 (filed Feb 26, 2026) · Latest quarter: 10-Q for the quarter ended Sep 30, 2026 (filed Oct 23, 2026) · Data pulled Oct 28, 2026

Key facts

CME Group (Nasdaq: CME) reported revenue of $6.5B for fiscal 2025, the year ended Dec 31, 2025, up 6.4% from fiscal 2024. Net income was $4.1B, up 15.5%. In its latest 10-Q, for the quarter ended Sep 30, 2026, revenue was $1.7B, up 13.0% from the same quarter a year earlier, and net income was $1.0B. The largest piece by product or service was clearing and transaction fees, at 81% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 26, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Oct 23, 2026).

Revenue$6.5BFY2025 · +6.4% vs FY2024
Net income$4.1BFY2025 · +15.5% vs FY2024
Revenue and net income, three fiscal yearsBy fiscal year, $bn
RevenueNet income
Revenue and net income by fiscal yearRevenue FY2023: $5.6B5.6Net income FY2023: $3.2B3.2FY2023Revenue FY2024: $6.1B6.1Net income FY2024: $3.5B3.5FY2024Revenue FY2025: $6.5B6.5Net income FY2025: $4.1B4.1FY2025

Source: 10-K FY2025, filed Feb 26, 2026

Quarterly revenue: fiscal 2026 vs a year earlierFiscal Q1–Q3, $bn (each quarter from that quarter's 10-Q)
FY2025FY2026
Quarterly revenue, fiscal 2026 vs 2025FY2025 Q1: $1.6B1.6FY2026 Q1: $1.9B1.9Q1FY2025 Q2: $1.7B1.7FY2026 Q2: $1.7B1.7Q2FY2025 Q3: $1.5B1.5FY2026 Q3: $1.7B1.7Q3

Source: 10-Q filed Apr 24, 2026 · 10-Q filed Jul 24, 2026 · 10-Q filed Oct 23, 2026

How it makes money

FY2025 total by categoryclearing and transaction fees: $5.3B (81%)MarketData: $803M (12%)OtherRevenue: $436M (7%)$6.5BFY2025 total

By product or service, FY2025

  • LineAmountSharevs FY2024
  • clearing and transaction fees$5.3B81%+5.9%
  • MarketData$803M12%+13.1%
  • OtherRevenue$436M7%+1.1%

Source: 10-K FY2025, XBRL breakdown

By product or service in FY2025: clearing and transaction fees (81%), MarketData (12%) and OtherRevenue (7%), as shares of total revenue. Total revenue was $6.5B.

By product or service: three-year mixShare of the total each fiscal year
clearing and transaction feesMarketDataOtherRevenue

Source: 10-K FY2025

Learn more: Revenue vs. net income · Gross, operating and net margin

What changed last quarter

How the quarter compared with a year earlier

Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)

Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.

Q3 2026Q3 2025

Company

Revenue
$1.7B Q3 2026
$1.5B Q3 2025
13.0% increase
Net income
$1.0B Q3 2026
$908M Q3 2025
14.2% increase

Source: CME Group 10-Q for the quarter ended Sep 30, 2026, filed Oct 23, 2026

By product or service

clearing and transaction fees
$1.4B Q3 2026
$1.2B Q3 2025
12.2% increase
MarketData
$243M Q3 2026
$202M Q3 2025
20.0% increase
OtherRevenue
$116M Q3 2026
$107M Q3 2025
8.3% increase

Source: CME Group 10-Q for the quarter ended Sep 30, 2026, filed Oct 23, 2026

The bull case and the bear case

The bull case

The bear case

  • The company's own risk factors are in Item 1A of its 10-K. Risks common in this industry include markets and rates; credit and claims; regulation. 10-K, Item 1A

What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.

What the company does

CME Group is in the financial exchanges & data industry, part of the financials sector. The SEC files it under Security & Commodity Brokers, Dealers, Exchanges & Services.

The full description of CME Group's business is in Item 1 of its 10-K, linked below. This page shows its revenue by product or service.

Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.

Source: 10-K, Item 1 Business

Risks common in this industry

These are general risks for companies in the financial exchanges & data industry. They are not a summary of CME Group’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.

  1. Markets and ratesInterest rates, credit conditions and market levels move its revenue and results.
  2. Credit and claimsLosses on loans, claims or investments can reduce earnings.
  3. RegulationCapital, liquidity and conduct rules affect what it can do and what it costs.
  4. CompetitionBanks, insurers, asset managers and technology firms compete for the same customers.
  5. Cyber and operationsSecurity incidents and operational failures can cause losses and harm trust.

Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)

Three years of key numbers

Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.

US$FY2023FY2024FY2025
Revenue$5.6B$6.1B$6.5B
Net income$3.2B$3.5B$4.1B
Diluted shares360M360M360M
  • Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
  • Net income: Net income attributable to the company's shareholders, after all costs, interest and taxes.
  • Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.

Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator

About these numbers

  • CME Group's revenue is the total revenue figure in its filings. For financial companies it can combine interest, fees, premiums and other income, so it isn't directly comparable with revenue at companies that sell products.

What we left out

  • Operating cash flow, total debt and cash are left out: for this kind of financial company they mostly reflect lending, trading or investing flows and say little about the business, and they aren't comparable with other companies'.

Recent filings

FormFiledPeriod
10-QOct 23, 2026Sep 30, 2026
10-QJul 24, 2026Jun 30, 2026
10-QApr 24, 2026Mar 31, 2026
DEF 14AMar 23, 2026Dec 31, 2025
10-KFeb 26, 2026Dec 31, 2025

Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters

Common questions about CME Group

How does CME Group make money?

CME Group's revenue was $6.5B in fiscal 2025. By product or service in FY2025: clearing and transaction fees (81%), MarketData (12%) and OtherRevenue (7%), as shares of total revenue. Total revenue was $6.5B. Source: 10-K for fiscal 2025, filed Feb 26, 2026.

What was CME Group's revenue in fiscal 2025?

$6.5B of revenue for the fiscal year ended Dec 31, 2025, up 6.4% from $6.1B in fiscal 2024. Fiscal 2023 was $5.6B. Source: 10-K for fiscal 2025, filed Feb 26, 2026.

Is CME Group profitable?

CME Group reported net income of $4.1B for fiscal 2025, up 15.5% from $3.5B in fiscal 2024. That is a profit under US accounting rules (GAAP). In the quarter ended Sep 30, 2026, net income was $1.0B. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 26, 2026.

What did CME Group report in its latest quarterly filing?

Revenue was $1.7B in the quarter ended Sep 30, 2026, up 13.0% from $1.5B a year earlier. Net income was $1.0B, up 14.2% from $908M. Source: 10-Q for the quarter ended Sep 30, 2026, filed Oct 23, 2026.

What are the main risks CME Group faces?

CME Group's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 26, 2026. Risks that are common among companies in the financial exchanges & data industry include Markets and rates; credit and claims; regulation; competition; cyber and operations. The first: Interest rates, credit conditions and market levels move its revenue and results. Source: 10-K, Item 1A Risk Factors.

Where do these CME Group numbers come from?

From CME Group's own SEC filings: the 10-K for fiscal 2025 (filed Feb 26, 2026) and the 10-Q for the quarter ended Sep 30, 2026 (filed Oct 23, 2026), read through the SEC's public XBRL data. Each number on this page links to its filing. Methodology explains how fiscal years and missing numbers are handled.

Disclosures

Editor holdings in CME
The editor holds no position in CME Group (CME). As of Oct 25, 2026.
Trading rule
The editor does not buy or sell CME from 3 days before to 3 days after this page is published or substantively updated.
Compensation
Nobody paid for this page. No affiliate links on this page.
Sources
The company's SEC filings, linked next to each number or, for charts, in the source line under them.
Last updated
Oct 28, 2026

General education, the same for every reader. Not a recommendation to buy, sell or hold CME, and it doesn't consider your situation.

More company files

New to filings? Learn has plain-English explainers and Tools has calculators. Methodology & Disclosures covers where every number comes from.